Loading page…
Laboratorios Farmaceuticos Rovi SA 2023 Integrated Report
Company: Laboratorios Farmaceuticos Rovi SA
Sector: Manufacturing
Country: Spain
Year: 2023
Type: Integrated Report
Pages: 239
The report describes ROVI’s 2023 performance, including 1% growth in operating revenue to 829.5 million euros. It reports 60% attainment of the 45 indicators in its ESG Master Plan. The Group also reports compensating all Scope 1 and 2 emissions and 15% of Scope 3 emissions, with 9.587 tonnes compensated.
Indicators available in this report: